Target intelligence / Profile preview

Apoptosis pathway in renal tubular epithelial cell

Molecular classification
Other
01

Overview

Apoptosis pathways in renal tubular epithelial cells refer to a collection of intracellular signaling cascades mediating programmed cell death in the kidney’s tubular epithelium. These pathways include the FAS/FAS-L–MAPK/JNK axis, activation of caspases via RANK/RANK-L, mitochondrial permeability transition regulated by Bcl-2 family proteins, and downstream release of cytochrome c leading to nuclear fragmentation and cell death. The balance between pro- and anti-apoptotic factors (such as Bax and Bcl-2) determines susceptibility to apoptosis. Pathological activation contributes to significant renal tubular cell loss in acute kidney injury, chronic kidney diseases, and diabetic nephropathy. Therapeutic efforts target upstream modulators (e.g., angiotensin II receptors, MAPK/JNK kinases), pro-apoptotic proteins, and signaling intermediates (e.g., SMYD2, RIPK3, GADD45B) to prevent inappropriate cell death. However, the term itself is not a canonical target but rather a functional process modulated by numerous, more discrete molecular entities.

Other names
Programmed cell death pathway in renal tubular epithelial cellTubular epithelial cell apoptosis pathway
02

Mechanism of action

Inhibition of key signaling intermediates that promote apoptosis (e.g., blocking angiotensin receptors, JNK/p38 pathway inhibition, inhibition of Bcl-2 family pro-apoptotic proteins, nAChR blockade, suppression of SMYD2 or RIPK3 activity)

03

Biological functions

Apoptosis
04

Disease associations

Acute kidney injuryChronic kidney diseaseDiabetic kidney disease
05

Safety considerations

Broad inhibition of apoptosis may impair normal tissue homeostasis and increase cancer risknon-specificity of interventions can result in systemic side effectskidney protection may be transient or incomplete if multiple cell death pathways coexist
06

Interacting drugs

Angiotensin receptor blockers

9 more in the full profile.

07

Biomarkers

BaxBcl-2C-caspase-3GADD45BRIPK3SMYD2nAChR subunits

Beyond the preview

Go deeper on Apoptosis pathway in renal tubular epithelial cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis pathway in renal tubular epithelial cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call